Key result
The Carpentier-Edwards biological valve demonstrated 78.5% survival at 5 years and 66% at 10 years, but was associated with a high incidence of tissue failure (18%) after 5 years.
Why the study?
What are the long-term survival and complication rates associated with the Carpentier-Edwards porcine valve bioprosthesis?
Cohort (n=299)
What are the long-term survival and complication rates associated with the Carpentier-Edwards porcine valve bioprosthesis?
The Carpentier-Edwards porcine bioprosthesis provides acceptable survival up to 10 years, but is associated with a high rate of tissue failure and need for reoperation after 5 years.
No takes yet. Share an insight, caveat, or question.
Supports caution with biological valves beyond 5 years; leaves open need for comparative durability trials.
Al‐Khaja et al. (1989) conducted a cohort in Valvular heart disease (n=299). Carpentier-Edwards porcine valve bioprosthesis was evaluated on Overall patient survival at 10 years. The Carpentier-Edwards biological valve demonstrated 78.5% survival at 5 years and 66% at 10 years, but was associated with a high incidence of tissue failure (18%) after 5 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: